Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Oteseconazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mycovia Presents VIVJOA® Safety Studies At IDSOG 2024
    Mycovia Presents VIVJOA® Safety Studies At IDSOG 2024

    01 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mycovia-pharmaceuticals-announces-presentation-of-results-from-three-safety-studies-evaluating-vivjoa-oteseconazole-in-subjects-with-renal-or-hepatic-impairment-and-the-impact-on-qt-prolongation-at-the-2024-idsog-annual-meetin-302211538.html

    PR NEWSWIRE
    01 Aug 2024
    Share Share
    Mycovia Announces AllianceRx Walgreens Pharmacy as Distributor of VIVJOA®
    Mycovia Announces AllianceRx Walgreens Pharmacy as Distributor of VIVJOA®

    26 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mycovia-pharmaceuticals-inc-announces-alliancerx-walgreens-pharmacy-and-walgreens-community-based-specialty-pharmacies-as-exclusive-distributor-of-vivjoa-302098255.html

    PR NEWSWIRE
    26 Mar 2024
    Share Share
    Mycovia Announces Partner Jiangsu Hengrui's Commercial Launch of VIVJOA
    Mycovia Announces Partner Jiangsu Hengrui's Commercial Launch of VIVJOA

    07 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mycovia-pharmaceuticals-inc-announces-partner-jiangsu-hengrui-pharmaceuticals-co-ltds-commercial-launch-of-vivjoa-oteseconazole-capsules-for-the-treatment-of-severe-vulvovaginal-candidiasis-vvc-in-china-302046980.html

    PR NEWSWIRE
    07 Feb 2024
    Share Share
    Mycovia Announces Partner Jiangsu Hengrui's Approval of Oteseconazole Capsules
    Mycovia Announces Partner Jiangsu Hengrui's Approval of Oteseconazole Capsules

    21 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mycovia-pharmaceuticals-inc-announces-partner-jiangsu-hengrui-pharmaceuticals-co-ltds-approval-of-oteseconazole-capsules-for-the-treatment-of-severe-vulvovaginal-candidiasis-vvc-in-china-301904626.html

    PR NEWSWIRE
    21 Aug 2023
    Share Share
    2022 drug approvals: Biopharma delivered 37 new drugs
    2022 drug approvals: Biopharma delivered 37 new drugs

    03 Jan 2023

    // Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/special-reports/2022-drug-approvals-after-aduhelm-fiasco-fda-endorsements-were-harder-come

    Kevin Dunleavy FIERCE PHARMA
    03 Jan 2023
    Share Share
    Mycovia Phase 3 ultraVIOLET Study Evaluating the Efficacy of VIVJOA in Women
    Mycovia Phase 3 ultraVIOLET Study Evaluating the Efficacy of VIVJOA in Women

    25 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220825005142/en

    BUSINESSWIRE
    25 Aug 2022
    Share Share